MAPT and Alzheimer disease: On the other hand, similar to other cerebral proteinopathies that are characterized by the existence of aggregated forms of proteins or peptides (e.g., amyloid‐β, tau, α‐synuclein, and TDP‐43), dissecting aggregation processes may provide a universal strategy for the development of disease‐modifying treatments against AD.